Glaucoma and optic nerve · AX
Glaucoma monitoring: target IOP, OCT / visual field and reports
Target IOP · OCT RNFL / GCL · Humphrey-class field · colour maps are not a verdict
Last reviewed: 2026-09-07 · 潘家健醫生
Key points
- Glaucoma monitoring covers target IOP, OCT (RNFL/GCL) and fields — report colours are not verdicts.
- No booking, referral or report scoring; no cure or guarantee claims.
- Acute angle-closure attack or sudden vision drop/blindness: A&E now (call 999 if needed).
- New clear field-cut sensation without emergency red flags: see an ophthalmologist promptly.
What it is
Public education on long-term glaucoma monitoring: teaching figures for target pressure, how structure (OCT) and function (visual field) are read together, and what colour maps on reports mean. This page does not score your report and does not teach DIY dose changes or stopping drops. Disease types (open-angle, normal-tension, ocular hypertension, angle closure) are on the glaucoma overview; five pressure-lowering drop classes are on the glaucoma drops page.
Why monitor
Lost nerve fibres and field usually do not return. In the spirit of the Early Manifest Glaucoma Trial (EMGT), lowering IOP may slow progression in some people — not a cure and not a personal guarantee. Monitoring usually includes IOP, structure (OCT RNFL / ganglion-cell–related measures) and function (Humphrey-class automated perimetry). Follow-up density follows risk and speed of change — not one timetable for everyone.
Target IOP (teaching)
Literature often discusses relative pressure drops: normal-tension glaucoma (CNTGS) commonly discusses a further drop of about 30%; ocular hypertension (OHTS) commonly discusses about 20%. Actual millimetre-of-mercury targets and percentage drops are decided only by an ophthalmologist; this page is not a visit.
Educational factors that may shape a target (a list, not a DIY score): optic-nerve damage, visual field, speed of change, age, thin cornea, disc haemorrhage, family history.
Structure and function: OCT / visual field
OCT colour maps are usually compared with that machine’s age norms: green often within a common statistical range, yellow borderline, red uncommon — statistical hints, not a verdict and not “already blind”. Macular / ganglion-cell complex (GCC and similar) is more sensitive to central-pattern loss. Humphrey-class field: mean deviation (MD) more negative usually means lower overall sensitivity; pattern standard deviation (PSD) reflects focal loss; glaucoma hemifield test (GHT) compares upper and lower halves. First tests often show a learning effect — repeat to build a baseline.
If OCT already shows clear thinning while the field is still relatively preserved, that is a time to discuss stronger IOP lowering to slow worsening — not a vision-preservation guarantee.
Worsening clues (education only — not self-diagnosis)
- Structure (OCT): larger cup–disc ratio, rim notches, disc haemorrhage, progressive RNFL / ganglion-cell–related thinning
- Function (visual field): clear MD worsening, new scotomas or central encroachment, progression analysis suggesting change (doctor interprets)
- IOP: persistently above target, or large swings — still combine with structure and function; one reading is not enough
What reports look like
- Green / yellow / red are often statistical colours vs that machine’s norms — not a court verdict
- Thickness numbers from different brands are usually not directly cross-comparable
- Red ≠ blind; false positives, poor fixation, cataract and small pupils all matter
- One bad field often needs a repeat before it means much
- Do not send report photos to non-treating clinicians as a formal reading
- This site will not score your report — bring the printout to follow-up
Go to A&E now (if you cannot get there: call 999)
- Acute angle-closure attack: severe red painful eye, headache and vomiting, rainbows, sudden vision drop — A&E now; if you cannot travel: call 999 (see urgent, glaucoma overview, hyperopia / shallow-chamber page)
- Sudden vision drop or sudden blindness
Same-day / scheduled follow-up
- If already diagnosed: keep the pressure / OCT / field schedule the doctor set — do not invent your own denser or looser plan
- New sense of field loss or tunnel vision without A&E red flags: see an ophthalmologist as soon as possible
- Do not stop, change doses or lend leftover drops yourself — see the glaucoma drops page
Selected public references (not a full bibliography)
These are the public studies this page draws on. PMID links go to PubMed (US National Library of Medicine) so you can check them. Figures are from those studies — not your prognosis and not a clinic success rate. Links are not a shop.
- Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701-713. PMID 12049574五年累積轉成開角型青光眼:用藥組 4.4%,觀察組 9.5%。不是人人必須即時用藥。
- Collaborative Normal-Tension Glaucoma Study Group The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126(4):498-505. PMID 9780094The intention-to-treat analysis showed no significant difference; after censoring cataract effects, the group with pressure lowered by about 30% worsened less. Surgery caused more cataract, so whether to lower pressure aggressively needs individual assessment.
- Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268-1279. PMID 12365904早期開角型青光眼:降眼壓減慢惡化。已失視野不能還原。
This is general medical information, not a diagnosis, and cannot replace an in-person consultation with a registered ophthalmologist, refraction, or a dilated fundus exam. It is not advice to use any medicine or undergo any procedure. Medicines (including off-label use), laser or surgery must be decided by a registered doctor after examination, according to indications and Hong Kong registration. Figures from the literature are published averages, not any clinic’s results. This site does not book, prescribe or refer. Do not change treatment on your own.